動物鎮靜劑市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

2024 年全球動物鎮靜劑市場價值為 1.674 億美元，預計 2025 年至 2034 年期間的複合年成長率為 6.5%，這得益於對先進獸醫護理和創新動物保健解決方案的需求激增。隨著全球範圍內寵物收養數量的不斷增加，尤其是在城市地區，寵物主人對寵物的健康越來越積極主動，尋求高品質的治療方案，包括安全有效的鎮靜劑。人們對動物健康、壓力管理和行為控制的認知不斷提高，推動了對有助於在手術、運輸和梳理過程中使動物平靜的鎮靜劑的需求。

此外，為了滿足對肉類和動物性食品日益成長的需求，畜牧業產量顯著增加，在醫療檢查、手術和運輸過程中處理農場動物的有效鎮靜方法的需求也得到了顯著的重視。獸醫專業人士也強調了無壓力處理和精確診斷的重要性，這導致接受手術、牙齒清潔和診斷成像的動物數量增加，而這些治療通常都需要鎮靜。伴侶動物中關節炎和癌症等慢性疾病的發生率不斷上升，使得它們需要頻繁地去看獸醫並接受治療，這進一步促進了動物鎮靜劑的使用。獸醫基礎設施和研究方面的投資不斷增加，以及鎮靜劑配方的技術進步，正在促進全球市場的成長，使動物鎮靜成為現代獸醫實踐的重要組成部分。

市場按藥物類別細分為吩噻嗪類、α-2 腎上腺素受體激動劑、苯二氮平類、丁醯苯類和其他類別。其中，吩噻嗪類藥物成為領先細分市場，2024 年銷售額達 6,600 萬美元，並因其廣泛的應用範圍而繼續佔據主導地位。獸醫普遍傾向於使用吩噻嗪類藥物進行麻醉前鎮靜、行為控制以及在運輸或梳理等緊張環境中緩解動物的痛苦。吩噻嗪類藥物有口服和注射兩種形式，具有靈活性和便利性，使其成為獸醫專業人士和寵物主人治療伴侶動物和牲畜的首選。它們已被證實能夠鎮靜動物，且沒有明顯的副作用，這使得它們成為市場上最值得信賴的鎮靜劑之一。

根據給藥途徑，市場分為口服和腸外給藥部分。預計 2025 年至 2034 年期間腸外給藥領域的複合年成長率將達到 6.3%，仍然是緊急手術、手術和診斷干預期間快速鎮靜的首選。腸外鎮靜劑對於確保立即產生鎮靜效果至關重要，對於執行需要動物保持靜止和無壓力的複雜程序的獸醫來說，它們是必不可少的。

2024 年北美動物鎮靜劑市場價值為 6,780 萬美元，這主要歸功於該地區先進的獸醫基礎設施以及對動物健康和福祉的日益關注。隨著獸醫護理變得越來越複雜，診斷和外科手術干預的數量不斷增加，對安全有效的鎮靜劑的需求持續上升。寵物主人和牲畜管理者都將動物的舒適度和安全放在首位，因此獸醫實踐中需要可靠的鎮靜選擇。

目錄

第1章：方法論與範圍

第2章：執行摘要

第3章：行業洞察

• 產業生態系統分析
• 產業衝擊力
  • 成長動力
    • 寵物擁有量增加
    • 動物外科手術的興起
    • 動物和人畜共通傳染病發生率不斷上升
    • 動物保健支出不斷增加，獸醫產品開發活動的投資不斷增加
  • 產業陷阱與挑戰
    • 與動物鎮靜劑相關的副作用
    • 政府對動物鎮靜劑的批准有嚴格的規定
    • 缺乏熟練的人才
• 成長潛力分析
• 監管格局
• 波特的分析
• PESTEL分析

第4章：競爭格局

• 介紹
• 公司矩陣分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 策略儀表板

第5章：市場估計與預測：按藥物類別，2021 - 2034 年

• 主要趨勢
• 吩噻嗪類
• α-2腎上腺素受體激動劑
• 苯二氮平類藥物
• 丁基苯類
• 其他藥物類別

第6章：市場估計與預測：按管理路線，2021 - 2034 年

• 主要趨勢
• 腸外
• 口服

第7章：市場估計與預測：按應用，2021 - 2034 年

• 主要趨勢
• 外科手術
• 診斷程序
• 臨床研究
• 其他應用

第8章：市場估計與預測：按動物類型，2021 - 2034 年

• 主要趨勢
• 小動物
  • 狗
  • 貓
  • 其他小動物
• 大型動物
  • 牛
  • 馬匹
  • 其他大型動物

第9章：市場估計與預測：按地區，2021 - 2034 年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 荷蘭
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第10章：公司簡介

• Bayer
• Boehringer Ingelheim Animal Health
• Ceva Animal Health
• Chanelle Pharma
• Dechra Pharmaceuticals
• Elanco Animal Health Incorporated
• Jurox Pty Limited
• Orion Corporation
• Virbac
• Zoetis

The Global Animal Sedatives Market was valued at USD 167.4 million in 2024 and is projected to grow at a CAGR of 6.5% between 2025 and 2034, driven by the surging demand for advanced veterinary care and innovative animal healthcare solutions. As pet adoption continues to rise worldwide, particularly in urban settings, owners are becoming increasingly proactive about their pets' health, seeking high-quality treatment options, including safe and effective sedatives. Growing awareness about animal wellness, stress management, and behavioral control is fueling the demand for sedatives that aid in calming animals during procedures, transportation, and grooming.

Additionally, with a notable increase in livestock production to meet the escalating demand for meat and animal-based food products, the requirement for effective sedation methods to handle farm animals during medical examinations, surgeries, and transportation has gained significant traction. Veterinary professionals are also emphasizing the importance of stress-free handling and precise diagnosis, which has led to a higher number of animals undergoing surgeries, dental cleanings, and diagnostic imaging, all of which often require sedation. The rising prevalence of chronic diseases among companion animals, including arthritis and cancer, necessitates frequent veterinary visits and treatments, further bolstering the use of animal sedatives. Increasing investments in veterinary infrastructure and research, along with technological advancements in sedative formulations, are contributing to market growth globally, making animal sedation an essential component of modern veterinary practices.

The market is segmented by drug class into phenothiazines, alpha-2 adrenergic receptor agonists, benzodiazepines, butyrophenones, and other categories. Among these, phenothiazines emerged as the leading segment, generating USD 66 million in 2024, and continue to dominate due to their wide range of applications. Veterinarians widely prefer phenothiazines for pre-anesthetic sedation, behavioral control, and easing animals in stressful environments such as transport or grooming sessions. Available in both oral and injectable forms, phenothiazines offer flexibility and convenience, making them a top choice among veterinary professionals and pet owners for both companion animals and livestock. Their proven efficacy in calming animals without significant side effects makes them one of the most trusted sedative classes in the market.

Based on route of administration, the market is bifurcated into oral and parenteral segments. The parenteral segment, anticipated to grow at a CAGR of 6.3% during 2025-2034, remains the preferred choice for fast-acting sedation during emergency procedures, surgeries, and diagnostic interventions. Parenteral sedatives are critical in ensuring immediate calming effects, making them indispensable for veterinarians performing complex procedures that require animals to remain still and stress-free.

North America Animal Sedatives Market was valued at USD 67.8 million in 2024, largely due to the region's advanced veterinary infrastructure and increasing focus on animal health and welfare. As veterinary care becomes more sophisticated, with a growing number of diagnostic and surgical interventions, the demand for safe and effective sedatives continues to rise. Pet owners and livestock managers alike are prioritizing animal comfort and safety, driving the need for reliable sedation options in veterinary practices.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing pet ownership
    • 3.2.1.2 Rising surgical procedures in animals
    • 3.2.1.3 Increasing incidences of animal and zoonotic diseases
    • 3.2.1.4 Increasing animal healthcare expenditure & growing investment in veterinary product development activities
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Side effects associated with animal sedatives
    • 3.2.2.2 Stringent government regulation for approval of animal sedatives
    • 3.2.2.3 Lack of skilled personnels
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Porter's analysis
• 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Drug Class, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Phenothiazines
• 5.3 Alpha-2 adrenergic receptor agonist
• 5.4 Benzodiazepines
• 5.5 Butyrophenones
• 5.6 Other drug classes

Chapter 6 Market Estimates and Forecast, By Route of Administration, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Parenteral
• 6.3 Oral

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Surgical procedures
• 7.3 Diagnostic procedures
• 7.4 Clinical research studies
• 7.5 Other applications

Chapter 8 Market Estimates and Forecast, By Animal Type, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Small animals
  • 8.2.1 Dogs
  • 8.2.2 Cats
  • 8.2.3 Other small animals
• 8.3 Large animals
  • 8.3.1 Cattle
  • 8.3.2 Horses
  • 8.3.3 Other large animals

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Italy
  • 9.3.5 Spain
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 Bayer
• 10.2 Boehringer Ingelheim Animal Health
• 10.3 Ceva Animal Health
• 10.4 Chanelle Pharma
• 10.5 Dechra Pharmaceuticals
• 10.6 Elanco Animal Health Incorporated
• 10.7 Jurox Pty Limited
• 10.8 Orion Corporation
• 10.9 Virbac
• 10.10 Zoetis